Cargando...
Impact of immunotherapy use in patients with stage IV pancreatic carcinoma
BACKGROUND: Most patients with pancreatic cancer have non-resectable disease at the time of diagnosis and usually die within 6–12 months. Despite indications in other solid tumors, the role of immunotherapy (IO) is unknown for late stage, advanced pancreatic cancer. METHODS: Using the National Cance...
Gardado en:
| Publicado en: | J Gastrointest Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AME Publishing Company
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7475322/ https://ncbi.nlm.nih.gov/pubmed/32953149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-191 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|